Evidence map›Paper›PMID 33900084›Full record

ArticleJournal of proteome research2021

TMTpro-18plex: The Expanded and Complete Set of TMTpro Reagents for Sample Multiplexing.

Jiaming Li, Zhenying Cai, Ryan D Bomgarden, Ian Pike, Karsten Kuhn, John C Rogers, Thomas M Roberts, Steven P Gygi, Joao A Paulo

Abstract read
In one paragraph

Article in Journal of proteome research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 168 papers.

0numbers the graph read from it
0cells of the map it votes in
168citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

168 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. SLC16A6 is a tyrosine transporter for the melanosome.bioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

108 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jiaming LiDepartment of Cell Biology, Harvard Medical School, Boston 02115, Massachusetts, United States.ORCID 0000-0002-9065-6913
Zhenying CaiDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston 02215, Massachusetts, United States.
Ryan D BomgardenThermo Fisher Scientific, Rockford 61101-9316, Illinois, United States.
Ian PikeProteome Sciences, London WC1H 9BB, U.K.
Karsten KuhnProteome Sciences, London WC1H 9BB, U.K.
John C RogersThermo Fisher Scientific, Rockford 61101-9316, Illinois, United States.
Thomas M RobertsDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston 02215, Massachusetts, United States.
Steven P GygiDepartment of Cell Biology, Harvard Medical School, Boston 02115, Massachusetts, United States.ORCID 0000-0001-7626-0034
Joao A PauloDepartment of Cell Biology, Harvard Medical School, Boston 02115, Massachusetts, United States.

Funding

New Sample Multiplexing Technologies to Identify Chemical Probes and Illuminate Ubiquitin BiologyR01GM067945 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI GYGI, STEVEN P · 2003 to 2024
$10.5M
Maximizing the Effectiveness of PI3K Inhibitors in the Treatment of Pten null CancersR35CA231945 · NCI · DANA-FARBER CANCER INST · PI ROBERTS, THOMAS M · 2019 to 2025
$7.1M
Advancing Multiplexed Isobaric Tag-based Strategies for Proteome ProfilingR01GM132129 · NIGMS · HARVARD MEDICAL SCHOOL · PI PAULO, JOAO A · 2019 to 2023
$1.7M
NCI NIH HHS R35 CA231945NIGMS NIH HHS R01 GM067945NIGMS NIH HHS R01 GM132129
6 · The paper itself

Abstract

The development of the TMTpro-16plex series expanded the breadth of commercial isobaric tagging reagents by nearly 50% over classic TMT-11plex. In addition to the described 16plex reagents, the proline-based TMTpro molecule can accommodate two additional combinations of heavy carbon and nitrogen isotopes. Here, we introduce the final two labeling reagents, TMTpro-134C and TMTpro-135N, which permit the simultaneous global protein profiling of 18 samples with essentially no missing values. For example, six conditions with three biological replicates can now be perfectly accommodated. We showcase the 18plex reagent set by profiling the proteome and phosphoproteome of a pair of isogenic mammary epithelial cell lines under three conditions in triplicate. We compare the depth and quantitative performance of this data set with a TMTpro-16plex experiment in which two samples were omitted. Our analysis revealed similar numbers of quantified peptides and proteins, with high quantitative correlation. We interrogated further the TMTpro-18plex data set by highlighting changes in protein abundance profiles under different conditions in the isogenic cell lines. We conclude that TMTpro-18plex further expands the sample multiplexing landscape, allowing for complex and innovative experimental designs.

Indexed as

ProteomeProteomicsCell LineIndicators and ReagentsPeptidesIndicators and ReagentsPeptidesProteome18plexBYL-719eclipseKIN-193MCF10APTENreal-time searchTMTpro

Identifiers

PMID33900084
PMCPMC8210943

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.